Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA: 600332)
China
· Delayed Price · Currency is CNY 27.41
-0.12 (-0.44%)
Jan 3, 2025, 3:00 PM CST
Guangzhou Baiyunshan Pharmaceutical Holdings Company Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 76,150 | 75,275 | 70,550 | 68,758 | 61,450 | 64,683 | Upgrade
|
| Other Revenue | 240.53 | 240.53 | 237.96 | 256.1 | 223.35 | 268.79 | Upgrade
|
| Revenue | 76,391 | 75,515 | 70,788 | 69,014 | 61,674 | 64,952 | Upgrade
|
| Revenue Growth (YoY) | 3.00% | 6.68% | 2.57% | 11.90% | -5.05% | 53.79% | Upgrade
|
| Cost of Revenue | 63,462 | 61,373 | 57,548 | 55,825 | 51,282 | 52,760 | Upgrade
|
| Gross Profit | 12,928 | 14,143 | 13,240 | 13,189 | 10,392 | 12,191 | Upgrade
|
| Selling, General & Admin | 7,994 | 8,484 | 8,062 | 7,955 | 6,396 | 7,696 | Upgrade
|
| Research & Development | 781.18 | 782.14 | 819.45 | 874.72 | 611.93 | 576.51 | Upgrade
|
| Other Operating Expenses | 220.31 | 252.21 | -182.76 | 294.43 | 257.59 | 295.21 | Upgrade
|
| Operating Expenses | 9,018 | 9,592 | 8,753 | 9,219 | 7,365 | 8,671 | Upgrade
|
| Operating Income | 3,910 | 4,551 | 4,487 | 3,970 | 3,026 | 3,520 | Upgrade
|
| Interest Expense | -430.66 | -446.19 | -434.41 | -417.83 | -363.34 | -393.65 | Upgrade
|
| Interest & Investment Income | 620.07 | 751.18 | 1,048 | 757.45 | 718.04 | 501.68 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.32 | 3.32 | -11.12 | 8.67 | 2.1 | -3.31 | Upgrade
|
| Other Non Operating Income (Expenses) | -18.53 | -30.48 | -41.12 | -94.44 | -66.85 | -28.81 | Upgrade
|
| EBT Excluding Unusual Items | 4,085 | 4,828 | 5,048 | 4,224 | 3,316 | 3,596 | Upgrade
|
| Gain (Loss) on Sale of Investments | 45.42 | 38.64 | -3.59 | 196.88 | -16.14 | 31.62 | Upgrade
|
| Gain (Loss) on Sale of Assets | 11.23 | 12.03 | 0.69 | 0.69 | 2.95 | 1.27 | Upgrade
|
| Asset Writedown | -8.07 | 0.42 | -7.06 | -3.08 | -2.89 | -2.41 | Upgrade
|
| Legal Settlements | - | - | - | -24.82 | -12.02 | -6 | Upgrade
|
| Other Unusual Items | 230.95 | 230.95 | 4.76 | 329.44 | 450.86 | 507.92 | Upgrade
|
| Pretax Income | 4,364 | 5,110 | 5,043 | 4,723 | 3,739 | 4,129 | Upgrade
|
| Income Tax Expense | 744.06 | 851.17 | 789.87 | 754.09 | 647.45 | 687.25 | Upgrade
|
| Earnings From Continuing Operations | 3,620 | 4,259 | 4,253 | 3,969 | 3,092 | 3,441 | Upgrade
|
| Minority Interest in Earnings | -196.64 | -203.65 | -286.85 | -249.11 | -176.38 | -252.4 | Upgrade
|
| Net Income | 3,423 | 4,056 | 3,967 | 3,720 | 2,915 | 3,189 | Upgrade
|
| Net Income to Common | 3,423 | 4,056 | 3,967 | 3,720 | 2,915 | 3,189 | Upgrade
|
| Net Income Growth | -20.08% | 2.25% | 6.63% | 27.60% | -8.58% | -7.33% | Upgrade
|
| Shares Outstanding (Basic) | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | Upgrade
|
| Shares Outstanding (Diluted) | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | Upgrade
|
| Shares Change (YoY) | 0.01% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 2.11 | 2.49 | 2.44 | 2.29 | 1.79 | 1.96 | Upgrade
|
| EPS (Diluted) | 2.11 | 2.49 | 2.44 | 2.29 | 1.79 | 1.96 | Upgrade
|
| EPS Growth | -20.08% | 2.25% | 6.63% | 27.61% | -8.57% | -7.33% | Upgrade
|
| Free Cash Flow | 1,167 | 2,475 | 5,615 | 4,419 | -291.32 | 2,623 | Upgrade
|
| Free Cash Flow Per Share | 0.72 | 1.52 | 3.45 | 2.72 | -0.18 | 1.61 | Upgrade
|
| Dividend Per Share | 1.149 | 0.749 | 0.732 | 0.687 | 0.538 | 0.589 | Upgrade
|
| Dividend Growth | 56.97% | 2.32% | 6.55% | 27.70% | -8.66% | 38.92% | Upgrade
|
| Gross Margin | 16.92% | 18.73% | 18.70% | 19.11% | 16.85% | 18.77% | Upgrade
|
| Operating Margin | 5.12% | 6.03% | 6.34% | 5.75% | 4.91% | 5.42% | Upgrade
|
| Profit Margin | 4.48% | 5.37% | 5.60% | 5.39% | 4.73% | 4.91% | Upgrade
|
| Free Cash Flow Margin | 1.53% | 3.28% | 7.93% | 6.40% | -0.47% | 4.04% | Upgrade
|
| EBITDA | 4,594 | 5,162 | 5,002 | 4,390 | 3,415 | 3,901 | Upgrade
|
| EBITDA Margin | 6.01% | 6.84% | 7.07% | 6.36% | 5.54% | 6.01% | Upgrade
|
| D&A For EBITDA | 683.84 | 611.24 | 514.44 | 419.91 | 388.93 | 380.5 | Upgrade
|
| EBIT | 3,910 | 4,551 | 4,487 | 3,970 | 3,026 | 3,520 | Upgrade
|
| EBIT Margin | 5.12% | 6.03% | 6.34% | 5.75% | 4.91% | 5.42% | Upgrade
|
| Effective Tax Rate | 17.05% | 16.66% | 15.66% | 15.97% | 17.32% | 16.65% | Upgrade
|
| Revenue as Reported | 875.45 | - | - | - | 61,674 | - | Upgrade
|
| Advertising Expenses | - | 1,082 | 960.69 | 1,054 | 690.74 | 1,327 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.